{"name":"Secretome Therapeutics","slug":"secretome-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxONGV1endvUHRmcldyTXR3U19GRHJoU2hlZVctNV82dm5tSE5WeTg0TDY5QU85ZmN2RVhlcGZJamJOM3Z0TlRsWTBHN200MEdFSHNWaTRhRjkwX2Vha0RPVzhfVGtOWlJ3Wm40cHJ5VG9lN1EzM2VKaUVwZUx0UTFYOGt0SWRlSlJFeEc3WVJnb0VzOVNvYWRQbVlqalhCMEN2MWZiZUJVb0xFNVFGUm5NY2VCb1ptanF0bDdTeUlrSzFKd1JONTl4ODhvT3hyM3dLbXc?oc=5","date":"2026-03-27","type":"pipeline","source":"Business Wire","summary":"Secretome Therapeutics Announces Participation in Upcoming Investor Conferences - Business Wire","headline":"Secretome Therapeutics Announces Participation in Upcoming Investor Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPU3NiN1dNaGJOTE9tSzBsRkVjQ1BWam5zNzdPcVpHSVh1LWpqMmxSS29HU2wyVHVWVUh5SXZCZENxNHVRRURaZ1VPSnFKd053Sm9KTXk2ekVsS29kUVVmYmZJRldoTVcyMHZsZ2MwSnROcHBSa3hyWlhJSlp1dl9vcmNNZTgwMDlKcnFiOGFMX2tmNG5MSnFsYmJjYzRmRXR2VndyN3Q5djBTSm16Y2ltVDFlaHpHY0lSMWw3YjhldGFsS3l5ei1EMWdYMWpPMjd6Smo5dXZ0S0lqRWVZN2E3a0d1QU1xNV9QVGRVSGpCeFpZVTRPZnJTLXZNaDREdExYellvYktJOXo1dWpVLTV3eW9ranFJN1JzSXFMd3hTd1lVaDJNSnc?oc=5","date":"2026-03-24","type":"pipeline","source":"PR Newswire","summary":"PPMD Provides $250,000 in Funding to Secretome Therapeutics Through PPMD Venture Pathways Program to Support Development of Cardiac Cell Therapy - PR Newswire","headline":"PPMD Provides $250,000 in Funding to Secretome Therapeutics Through PPMD Venture Pathways Program to Support Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPOGl1RlVuYnN4UGpZc3NnV2dqckdqem9XZDlMZUdFOWJ6TGRLWVR0YnVWSk9FbmxPUmlSdVktUGJGRHFKUXNsYU41T3JWcUFRalVjdmFFNkFJQWZCY0NwVzEtNnY5NkxpeG10T2d2a0tEeERYcjVhc0JycDBzdnY3SnVIRWVsX1cyTmJoOC1NdlVTZ1ZDd0hjV0U3SlhhU2lyVkNXb0N5cW1fTmxySGlIckJOSUpqbk84SmpVQlhtRFF2elNzd0FEd2hySktUdi1MeGc?oc=5","date":"2025-12-29","type":"pipeline","source":"Business Wire","summary":"Secretome Therapeutics to Present at the 2026 J.P. Morgan Healthcare Conference - Business Wire","headline":"Secretome Therapeutics to Present at the 2026 J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxOSEJzOFRiUnV4MjE2TXFmLVJCTXdIeU95OC1lTWFHNUFvT0RfOHZqdzBOQlU0VnJNUmxJM09TZm9BNW5xMmU2OWs1NWctSThhRktXcHIyemZlS19GNWFUS0VFejNObHN6YjAzWHVTS1JGUnJha0lSWVp1RDZiSXhFTE13VzFLaUhHamR4UExGWjY0cVN4WXJyalBGX0RkSjExV29NV3JobHRWMWE4QU9KLTFwYjZyNlF1QVA0V0tSOUtiU0FFNXpBYko1QzFqWExJeTRMdzZGcHZVU1laSWFReHNNU2ZLQ1dTTmE3QnhwS2FsZHIz?oc=5","date":"2025-10-28","type":"trial","source":"Business Wire","summary":"Secretome Therapeutics Initiates Phase 1 Clinical Trial of STM-01 in Patients with Dilated Cardiomyopathy - Business Wire","headline":"Secretome Therapeutics Initiates Phase 1 Clinical Trial of STM-01 in Patients with Dilated Cardiomyopathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPdFQ2cE15b2o2U3pNY3dMclBUX3g5V2xaWFRSZ0hjbXJINnFpdlV0OGVWd2NlejRjQUNlVzlFNnVuT1luSXBmdFZ2WkFXajNOYmk5RW1iQVF1eWJ5SmlBM0RxT3pYMEp3QjBGQ2JwalRLMmo5a1E5Tms5cVppcFJPNG53dU9PcWU1ckdKX25n?oc=5","date":"2025-09-30","type":"trial","source":"The Pharma Letter","summary":"Kala Bio tanks on Phase IIb KPI-012 miss - The Pharma Letter","headline":"Kala Bio tanks on Phase IIb KPI-012 miss","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPWnNJWVNiUnhVcDBNMk1wZTRUT1pKeWZDeGJkam1yS0xuT1c3RUZ2aThETVBkTG5qeGdpLS1kbHozbHd2ZmNtNllUYjY0c0VBdVlqOW5EQURRajRwWEs5UEFXem5GcTRsdlp4Vk96elg2aXBOenhxWmRQSVFFR1Zxc2NWdXJfX1VKVzFMX09GMngzMnc?oc=5","date":"2025-06-06","type":"pipeline","source":"nia.nih.gov","summary":"NIA Small Business Showcase: Juvena Therapeutics, Inc. - nia.nih.gov","headline":"NIA Small Business Showcase: Juvena Therapeutics, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNdWV4bjJsWWk1Mk5iRWlSQzZoNnVXT3FnZEpwM2ZWVHNzX2Y5NTU2aTZYUTFvcDBjZzRlczdmMGUzUThvRTRjc2g3SzhveE1Pb3FvOEdVU2hWdkZnV3ktRUR6aS1fblRPT25aaW9iRXFES3RoaFN2UXNRMnlFSWY3ZmRRYzJ2Vy1qRWdmeFFwOA?oc=5","date":"2025-04-23","type":"pipeline","source":"Dallas Innovates","summary":"Secretome Therapeutics Appoints New Chief Medical Officer - Dallas Innovates","headline":"Secretome Therapeutics Appoints New Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOOWFGRDVJYmMwcjhudDNGeklpRlNxQ0ZNcUF2M0F4VlFWRkV1RWVvSUJlRmF6TVBmbzhlS3FlbjA0NEdaRlBWbGZtWmxmZFZTaGtXOHRjMG1GTUZOWnBOSEVIaXd0b05RS3E0OEJ4Z3hwYm9hUVZKLTZVdVBRVUV1dnRDSTZUYXZ2Y0FGTGRCcUZvdjMwa25Odi1HZmZwS3JBMm14NDV5Vlp6SUZNNUlLdDJrQnZ1MkZCRW81TU5B?oc=5","date":"2025-04-22","type":"pipeline","source":"citybiz","summary":"Secretome Therapeutics Appoints Dr. Marshelle Smith Warren as Chief Medical Officer - citybiz","headline":"Secretome Therapeutics Appoints Dr. Marshelle Smith Warren as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNQWdfNlBsSEl0U1l0VTNkdWktLTJvZ3hXdEVMV1BYYlVXNkxwTE5FbWFwbHBWRi14UXFnYVZXUEZXZmY5cFpGVEpsdGh0M0NrRHpydXl6QWFxT1dtZXBjRGRDc0NYWTAyQWtUb0Q2RUQ1VFcxaG5QenRjR09saGl2dWZyclFLZ1gxalZqdjBYOHdTelpXS2FzRXQyVHo3UFlibGRDblpnYXNvenFtbEJaaXhFZlVHUnJjSmhQanZyNmw?oc=5","date":"2025-01-23","type":"deal","source":"Contract Pharma","summary":"Cellipont, Secretome Partner for cGMP Manufacturing of STM-01 Cellular Therapy - Contract Pharma","headline":"Cellipont, Secretome Partner for cGMP Manufacturing of STM-01 Cellular Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPWGRjTmYyeTlGdkJIaXJpLXdBQjJ0X2lpWXcxR2p1Y1F5U2ZlUWJ6X2l3c0UtblJwWEM0eHZBM08tSlpOUFp5ajgtNlRqYVZMZlJ5a1l5U3RaTTc5Z0YxTkVES3VTWTFHOWdVY3Frak1UMUZ2VV9ON0Z5WkVJREZ6R2JPN1Z5OWRPWUhXRnBuWUo3LWlPYVV3R2RCOXFjX1p4ZnppbVE0RWgtX3BpRGhIZ21sVTdwajZsM0xuWTI2cHFoRnI4RzRSOVlUbmNYNmtIN1RKdjBDcktMVmJILUV0elhoZHF4di0ydG5EUENxRVdiTVpUM2VOLXBxVTlBSEZOVVItdnI5QkpzUQ?oc=5","date":"2025-01-22","type":"deal","source":"PR Newswire","summary":"Cellipont Bioservices and Secretome Therapeutics Partner for cGMP Manufacturing for Master Cell Bank for Lead Asset STM-01 - PR Newswire","headline":"Cellipont Bioservices and Secretome Therapeutics Partner for cGMP Manufacturing for Master Cell Bank for Lead Asset STM-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWVh0Vk13ZmczUGxnZWZ4Sl91MWsxekdxVERQTndwM0tKSHU4OE1NUGpld2JTZWZYLVZDUGR2cGo0TklXbExrZ20tbFRTUllwYkFHb2ZmeU9PSUNhYnhaUU1sZ0dFWVg3N0FEUXRramEtNW16RGo3ZWFnZmtITWljcWdQSzVyWGlZX0c5QkFGWXpjTGVfS1RaSXU5RzI0bktONTIwQWJ5cUVYMHhCaFBEa0YyVDk4aVVVRFZYQXcxRmlyQ3A0Z3M2MlRRV2ZkdmZkeFYxcmpXdTRFRDR4X0QtMUhKZTBpQjg?oc=5","date":"2024-11-26","type":"pipeline","source":"BioSpace","summary":"Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies - BioSpace","headline":"Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOMi1vLXExcEUwbllBcWFodk5vdVhLMWFuUzV3T0FmdTJaZ05ZdXFVNTl1SzgzclgySUwzcUhnYzFncVpOcVpVRzdkQ1drS05tZzZ1VVp3Y1g1MEVzeGlSR0Z5ZEJyMzVKbFlfTWRUYUktNWUtNEVRMnctd3Z2OUpXZkxTTUg4UG5KWFFnVkhsZkdfVXp2U3lSM3hNdUcwZldNOGV2OFlOTktMR0JwbzlISkFHMF9HNkVheW5IQlNoYVRHc2xvYVVMVWJvNElaQWhhNFE?oc=5","date":"2023-06-29","type":"pipeline","source":"RegMedNet","summary":"Cell therapy weekly: Vertex and Lonza to build joint manufacturing facility for Type 1 diabetes cell therapies - RegMedNet","headline":"Cell therapy weekly: Vertex and Lonza to build joint manufacturing facility for Type 1 diabetes cell therapies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}